|
1
|
Rampone B, Schiavone B, Martino A, Viviano
C and Confuorto G: Current management strategy of hepatocellular
carcinoma. World J Gastroenterol. 15:3210–3216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rahbari NN, Mehrabi A, Mollberg NM, Müller
SA, Koch M, Büchler MW and Weitz J: Hepatocellular carcinoma:
current management and perspectives for the future. Ann Surg.
253:453–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Merle P and Mornex F: Medical therapies
for hepatocellular carcinoma. Cancer Radiother. 15:28–31. 2011.
|
|
5
|
Llovet JM, Fuster J and Bruix J: The
Barcelona approach: diagnosis, staging, and treatment of
hepatocellular carcinoma. Liver Transpl. 10:S115–S120. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vogel S, Ohmayer S, Brunner G and Heilmann
J: Natural and non-natural prenylated chalcones: synthesis,
cytotoxicity and anti-oxidative activity. Bioorg Med Chem.
16:4286–4293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang J, Li N, Dai H and Wang K: Chemical
constituents from seeds of Alpinia katsumadai, inhibition on
NF-kappaB activation and anti-tumor effect. Zhongguo Zhong Yao Za
Zhi. 35:1710–1714. 2010.PubMed/NCBI
|
|
8
|
He W, Li Y, Tang J, Luan F, Jin J and Hu
Z: Comparison of the characterization on binding of alpinetin and
cardamonin to lysozyme by spectroscopic methods. Int J Biol
Macromol. 39:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Zhou L, He W and Hu Z: Separation
and determination of alpinetin and cardamonin by reverse micelle
electrokinetic capillary chromatography. J Pharm Biomed Anal.
43:1557–1561. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malek SN, Phang CW, Ibrahim H, Norhanom AW
and Sim KS: Phytochemical and cytotoxic investigations of
Alpinia mutica rhizomes. Molecules. 16:583–589. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
In LL, Azmi MN, Ibrahim H, Awang K and
Nagoor NH: 1′S-1′-acetoxyeugenol acetate: a novel phenylpropanoid
from Alpinia conchigera enhances the apoptotic effects of
paclitaxel in MCF-7 cells through NF-κB inactivation. Anticancer
Drugs. 22:424–434. 2011.
|
|
12
|
He ZH, Ge W, Yue GG, Lau CB, He MF and But
PP: Anti-angiogenic effects of the fruit of Alpinia
oxyphylla. J Ethnopharmacol. 132:443–449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki A, Guicheux J, Palmer G, Miura Y,
Oiso Y, Bonjour JP and Caverzasio J: Evidence for a role of p38 MAP
kinase in expression of alkaline phosphatase during osteoblastic
cell differentiation. Bone. 30:91–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Molton SA, Todd DE and Cook SJ: Selective
activation of the c-Jun N-terminal kinase (JNK) pathway fails to
elicit Bax activation or apoptosis unless the phosphoinositide
3′-kinase (PI3K) pathway is inhibited. Oncogene. 22:4690–4701.
2003.
|
|
15
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dérijard B, Raingeaud J, Barrett T, Wu IH,
Han J, Ulevitch RJ and Davis RJ: Independent human MAP-kinase
signal transduction pathways defined by MEK and MKK isoforms.
Science. 267:682–685. 1995.
|
|
17
|
Kishimoto H, Nakagawa K, Watanabe T,
Kitagawa D, Momose H, Seo J, Nishitai G, Shimizu N, Ohata S,
Tanemura S, Asaka S, Goto T, Fukushi H, Yoshida H, Suzuki A, Sasaki
T, Wada T, Penninger JM, Nishina H and Katada T: Different
properties of SEK1 and MKK7 in dual phosphorylation of
stress-induced activated protein kinase SAPK/JNK in embryonic stem
cells. J Biol Chem. 278:16595–16601. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tournier C, Dong C, Turner TK, Jones SN,
Flavell RA and Davis RJ: MKK7is an essential component of the JNK
signal transduction pathway activated by proinflammatory cytokines.
Genes Dev. 15:1419–1426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Finch A, Holland P, Cooper J, Saklatvala J
and Kracht M: Selective activation of JNK/SAPK by interleukin-1 in
rabbit liver is mediated by MKK7. FEBS Lett. 418:144–148. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Destrument A and Tournier C:
Physiological roles of MKK4 and MKK7: insights from animal models.
Biochim Biophys Acta. 1773:1349–1357. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi JE, Hur W, Jung CK, Piao LS, Lyoo K,
Hong SW, Kim SW, Yoon HY and Yoon SK: Silencing of 14-3-3ζ
over-expression in hepatocellular carcinoma inhibits tumor growth
and enhances chemosensitivity to cis-diammined dichloridoplatium.
Cancer Lett. 303:99–107. 2011.
|
|
22
|
Raman M, Chen W and Cobb MH: Differential
regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saito H: Regulation of cross-talk in yeast
MAPK signaling pathways. Curr Opin Microbiol. 13:677–683. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galeotti N and Ghelardini C: Regionally
selective activation and differential regulation of ERK, JNK and
p38 MAP kinase signalling pathway by protein kinase C in mood
modulation. Int J Neuropsychopharmacol. 20:1–13. 2011.PubMed/NCBI
|
|
25
|
Huang P, Han J and Hui L: MAPK signaling
in inflammation-associated cancer development. Protein Cell.
1:218–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bermudez O, Pagès G and Gimond C: The
dual-specificity MAP kinase phosphatases: critical roles in
development and cancer. Am J Physiol Cell Physiol. 299:C189–C202.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haeusgen W, Herdegen T and Waetzig V: The
bottleneck of JNK signaling: molecular and functional
characteristics of MKK4 and MKK7. Eur J Cell Biol. 90:536–544.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hammaker DR, Boyle DL, Inoue T and
Firestein GS: Regulation of the JNK pathway by TGF-beta activated
kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther.
9:R572007. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tu Z, Mooney SM and Lee FS: A subdomain of
MEKK1 that is critical for binding to MKK4. Cell Signal. 15:65–77.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Q, Tian H, Fu X and Zhang G: Delayed
activation and regulation of MKK7 in hippocampal CA1 region
following global cerebral ischemia in rats. Life Sci. 74:37–45.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takekawa M, Tatebayashi K and Saito H:
Conserved docking site is essential for activation of mammalian MAP
kinase kinases by specific MAP kinase kinase kinases. Mol Cell.
18:295–306. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mooney LM and Whitmarsh AJ: Docking
interactions in the c-Jun N-terminal kinase pathway. J Biol Chem.
279:11843–11852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mondal S and Mandal C, Sangwan R, Chandra
S and Mandal C: Withanolide D induces apoptosis in leukemia by
targeting the activation of neutral sphingomyelinase-ceramide
cascade mediated by synergistic activation of c-Jun N-terminal
kinase and p38 mitogen-activated protein kinase. Mol Cancer.
9:2392010.
|
|
34
|
Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL,
Yu CS, Lin ML, Yang JS, Kuo HM, Wu SH and Chung JG: Phenethyl
isothiocyanate inhibits migration and invasion of human gastric
cancer AGS cells through suppressing MAPK and NF-kappaB signal
pathways. Anticancer Res. 30:2135–2143. 2010.PubMed/NCBI
|
|
35
|
Dai Y, Guzman ML, Chen S, Wang L, Yeung
SK, Pei XY, Dent P, Jordan CT and Grant S: The NF (Nuclear
factor)-κB inhibitor parthenolide interacts with histone
deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in
human acute myeloid leukaemia cells. Br J Haematol. 151:70–83.
2010.
|
|
36
|
Terada Y, Nakashima O, Inoshita S,
Kuwahara M, Sasaki S and Marumo F: Mitogen-activated protein kinase
cascade and transcription factors: the opposite role of MKK3/6-p38K
and MKK1-MAPK. Nephrol Dial Transplant. 1:45–47. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Taylor JL, Szmulewitz RZ, Lotan T, Hickson
J, Griend DV, Yamada SD, Macleod K and Rinker-Schaeffer CW: New
paradigms for the function of JNKK1/MKK4 in controlling growth of
disseminated cancer cells. Cancer Lett. 272:12–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
